M T Mbizvo1, J Kasule, K Mahomed, K Nathoo. 1. Department of Obstetrics and Gynaecology, University of Zimbabwe Medical School, Avondale, Harare, Zimbabwe. mbizvom@who.ch
Abstract
OBJECTIVE: To estimate the incidence of HIV seroconversion among women following pregnancy and delivery. DESIGN: A prospective cohort of women who were HIV negative at recruitment on first antenatal care visit. MATERIALS AND METHODS: Pregnant women were invited to undergo voluntary confidential HIV counselling and blood draw for HIV testing during the first antenatal care visit as part of a prospective study of mother-to-child transmission of HIV-1. Repeat tests were conducted at delivery, six weeks post partum and at three monthly intervals until 24 months or on termination due to subsequent pregnancy, death or loss to follow up. Logistic regression modelling was used to determine independent predictors of HIV seroconversion. RESULTS: Among 372 HIV negative pregnant women who were enrolled, 66 seroconverted during follow up, resulting in a sero-incidence of 4.8 per 100 person years (95% confidence interval [CI], 3.1 to 6.5). Women who did not seroconvert during the time of pregnancy or follow up were significantly more likely to have used a condom with their partners (OR = 0.68, 95% CI = 0.47 to 0.99). Women aged 17 years and below had the highest seroconversion incidence (6.25%) followed by those aged 18 to 19 years (5.42%). Women who seroconverted and those who were HIV positive at recruitment were more likely to be married. Lack of education by the partner of a pregnant woman constituted a significant risk factor for HIV seroconversion (OR = 2.8; 95% CI = 1.1 to 11.0). CONCLUSIONS: There is a high HIV seroconversion incidence among women during pregnancy and following delivery, especially those aged 19 years and below. Being married does not protect the women from the risk of HIV seroconversion. Strategies for HIV prevention should target pregnant women and their partners.
OBJECTIVE: To estimate the incidence of HIV seroconversion among women following pregnancy and delivery. DESIGN: A prospective cohort of women who were HIV negative at recruitment on first antenatal care visit. MATERIALS AND METHODS: Pregnant women were invited to undergo voluntary confidential HIV counselling and blood draw for HIV testing during the first antenatal care visit as part of a prospective study of mother-to-child transmission of HIV-1. Repeat tests were conducted at delivery, six weeks post partum and at three monthly intervals until 24 months or on termination due to subsequent pregnancy, death or loss to follow up. Logistic regression modelling was used to determine independent predictors of HIV seroconversion. RESULTS: Among 372 HIV negative pregnant women who were enrolled, 66 seroconverted during follow up, resulting in a sero-incidence of 4.8 per 100 person years (95% confidence interval [CI], 3.1 to 6.5). Women who did not seroconvert during the time of pregnancy or follow up were significantly more likely to have used a condom with their partners (OR = 0.68, 95% CI = 0.47 to 0.99). Women aged 17 years and below had the highest seroconversion incidence (6.25%) followed by those aged 18 to 19 years (5.42%). Women who seroconverted and those who were HIV positive at recruitment were more likely to be married. Lack of education by the partner of a pregnant woman constituted a significant risk factor for HIV seroconversion (OR = 2.8; 95% CI = 1.1 to 11.0). CONCLUSIONS: There is a high HIV seroconversion incidence among women during pregnancy and following delivery, especially those aged 19 years and below. Being married does not protect the women from the risk of HIV seroconversion. Strategies for HIV prevention should target pregnant women and their partners.
Authors: Cynthia L Gay; Victor Mwapasa; David M Murdoch; Jesse J Kwiek; Susan A Fiscus; Steven R Meshnick; Myron S Cohen Journal: Diagn Microbiol Infect Dis Date: 2010-04 Impact factor: 2.803
Authors: Nelly R Mugo; Renee Heffron; Deborah Donnell; Anna Wald; Edwin O Were; Helen Rees; Connie Celum; James N Kiarie; Craig R Cohen; Kayitesi Kayintekore; Jared M Baeten Journal: AIDS Date: 2011-09-24 Impact factor: 4.177
Authors: John Kinuthia; James N Kiarie; Carey Farquhar; Barbra Richardson; Ruth Nduati; Dorothy Mbori-Ngacha; Grace John-Stewart Journal: Curr HIV Res Date: 2010-10 Impact factor: 1.581
Authors: Simon Gregson; Elizabeth Gonese; Timothy B Hallett; Noah Taruberekera; John W Hargrove; Ben Lopman; Elizabeth L Corbett; Rob Dorrington; Sabada Dube; Karl Dehne; Owen Mugurungi Journal: Int J Epidemiol Date: 2010-04-20 Impact factor: 7.196
Authors: Lauren A Graybill; Margaret Kasaro; Kellie Freeborn; Jennifer S Walker; Charles Poole; Kimberly A Powers; Katie R Mollan; Nora E Rosenberg; Sten H Vermund; Wilbroad Mutale; Benjamin H Chi Journal: AIDS Date: 2020-04-01 Impact factor: 4.632
Authors: John D T Lawi; Mariam M Mirambo; Moke Magoma; Martha F Mushi; Hyasinta M Jaka; Balthazary Gumodoka; Stephen E Mshana Journal: BMC Pregnancy Childbirth Date: 2015-01-22 Impact factor: 3.007
Authors: Milly Marston; Marie Louise Newell; Amelia Crampin; Tom Lutalo; Richard Musoke; Simon Gregson; Constance Nyamukapa; Jessica Nakiyingi-Miiro; Mark Urassa; Raphael Isingo; Basia Zaba Journal: PLoS One Date: 2013-12-26 Impact factor: 3.240
Authors: Caroline De Schacht; Nédio Mabunda; Orlando C Ferreira; Nália Ismael; Nurbai Calú; Iolanda Santos; Heather J Hoffman; Catharina Alons; Laura Guay; Ilesh V Jani Journal: J Int AIDS Soc Date: 2014-03-05 Impact factor: 5.396